Isabel Cunningham, MD
| Profession: | Adjunct Associate Research Scientist, Division of Oncology, Columbia University College of Physicians and Surgeons |
| Member since: | 2007 Oct 1 |
Recent Posts
Taking Aim at del (17p13) in Myeloma
Dr. Isabel Cunningham: Treatment of Myeloproliferative Neoplasms Comes of Age
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Chemotherapy Alone Bests Radiation for Nonbulky Hodgkin's Lymphoma
Genetics May Play Role in Anthracycline-Induced Cardiomyopathy
A View on Leukemia News From ASCO 2011
Zalutumumab Plus Best Supportive Care Beneficial In SCCHN
Pralatrexate Effective in Relapsed/Refractory Peripheral T-Cell Lymphoma
8-Year Follow-Up of Imatinib-Treated Ph+ CML in CCyR After AutoSCT
Dr. Isabel Cunningham: Improving AML Results. Hint: It's Not (Yet) a Drug
Bio
Biographical Sketch:
With broad experience in both academic oncology and clinical research, Dr. Cunningham provides a crucial bridge between community and academic medicine. Dr. Cunningham received her AB from Bryn Mawr College and her MD from Yale University School of Medicine. Her postgraduate training included a fellowship in hematology-oncology and bone marrow transplant at Memorial Sloan-Kettering Cancer Center. Dr. Cunningham has held academic positions at Memorial Sloan-Kettering and several other universities, and she is currently conducting research at Columbia University. She serves on the Board of Directors of the New York City Chapter of the Leukemia & Lymphoma Society. She has published extensively and has been a reviewer for Blood
, Bone Marrow Transplantation
, Experimental Hematology
, and Leukemia & Lymphoma
.
Positions:
Adjunct Associate Research Scientist, Columbia University
Member, Board of Directors, Leukemia & Lymphoma Society
Degrees:
Bryn Mawr College, AB
Yale University School of Medicine, MD
Postgraduate Training:
Resident, hematology/oncology and bone marrow transplant, Presbyterian Hospital, New York
Fellow, Memorial Sloan-Kettering Cancer Center
Board Certifications:
Internal medicine
Hematology
Clinical Interests:
Hematologic malignancies
Sign up for our newsletters
Too busy to follow cancer's top stories? Sign-up for one or more of our leading newsletters -- delivered weekly to your inbox.